Our results on GSTM1genotype are in agreement with those of Lizard-Nacol et al. [40] who, showed no effect of GSTM1-null genotype on DFS or OS among 92 women with advanced BC who had received cyclophosphamide, doxorubicin, and 5-FU. Here, GSTM1 is linked to breast cancer.